Agentix Corp. SEC filings AGTX
Agentix Corp. has 153 filings in SEC EDGAR's recent list, going back to Apr 1, 2014. Its latest annual report, Form 10-K, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 14, 2022 (officer or director change). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Jul 1, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 20, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 22, 2025 | Jun 30, 2025 |
| NT 10-Q | Filing | Aug 15, 2025 | Jun 30, 2025 |
| 10-K | Annual report | Jul 16, 2025 | Mar 31, 2025 |
| NT 10-K | Form nt 10-k | Jul 1, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Feb 18, 2025 | Dec 31, 2024 |
| NT 10-Q | Filing | Feb 14, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 18, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Sep 25, 2024 | Jun 30, 2024 |
| 10-K | Annual report | Aug 30, 2024 | Mar 31, 2024 |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| NT 10-K | Filing | Jul 1, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 20, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 22, 2023 | Jun 30, 2023 |
| NT 10-Q | Filing | Aug 14, 2023 | Jun 30, 2023 |
| 10-K | Annual report | Jul 14, 2023 | Mar 31, 2023 |
| NT 10-K | Filing | Jun 29, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Feb 14, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 10-KT | Transition report | Jul 18, 2022 | Mar 31, 2022 |
| NT 10-K | Filing | Jun 30, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 14, 2022 | Jun 11, 2022 |
| 10-Q | Quarterly report | Apr 13, 2022 | Feb 28, 2022 |
| RW | Filing | Mar 11, 2022 | — |
| 10-Q | Quarterly report | Jan 13, 2022 | Nov 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 21, 2021 | Dec 20, 2021 |
| 10-K | Annual report | Oct 7, 2021 | Aug 31, 2021 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jul 16, 2021 | Jul 14, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 14, 2021 | Jul 13, 2021 |
| 10-Q | Quarterly report | Jul 9, 2021 | May 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2021 | Jun 4, 2021 |
| 8-K |
Current report
Material agreement
|
May 27, 2021 | May 21, 2021 |
| 10-Q | Quarterly report | Mar 29, 2021 | Feb 28, 2021 |
| D | Filing | Feb 11, 2021 | — |
| 10-Q | Quarterly report | Jan 13, 2021 | Nov 30, 2020 |
| S-8 POS | Filing | Jan 8, 2021 | — |
| S-8 | Employee stock plan registration | Jan 4, 2021 | — |
| 424B3 | Prospectus | Dec 29, 2020 | — |
| EFFECT | Filing | Dec 23, 2020 | — |
| CORRESP | Letter to the SEC | Dec 11, 2020 | — |
| POS AM | Filing | Dec 11, 2020 | — |
| 10-K | Annual report | Dec 9, 2020 | Aug 31, 2020 |
| NT 10-K | Filing | Nov 30, 2020 | Aug 31, 2020 |
| 10-K/A | Amended annual report | Nov 23, 2020 | Aug 31, 2019 |
| UPLOAD | Letter from the SEC | Nov 13, 2020 | — |
| POS AM | Filing | Nov 4, 2020 | — |
| EFFECT | Filing | Sep 23, 2020 | — |
| 424B3 | Prospectus | Sep 23, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| CORRESP | Letter to the SEC | Sep 17, 2020 | — |
| S-1/A | Amended registration statement | Sep 17, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2020 | — |
| CORRESP | Letter to the SEC | Sep 15, 2020 | — |
| S-1/A | Amended registration statement | Sep 15, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2020 | — |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Sep 9, 2020 | May 28, 2020 |
| S-1 | Registration statement | Sep 3, 2020 | — |
| 8-K |
Current report
Other events
|
Jul 30, 2020 | Jun 15, 2020 |
| 10-Q | Quarterly report | Jul 13, 2020 | May 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2020 | Jul 2, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control
|
May 29, 2020 | May 28, 2020 |
| 8-K |
Current report
Officer or director change
|
May 13, 2020 | May 8, 2020 |
| 10-Q | Quarterly report | Apr 27, 2020 | Feb 29, 2020 |
| NT 10-Q | Form 10-q | Apr 14, 2020 | Feb 29, 2020 |
| 10-Q | Quarterly report | Jan 16, 2020 | Nov 30, 2019 |
| 10-K | Annual report | Dec 5, 2019 | Aug 31, 2019 |
| NT 10-K | Filing | Dec 3, 2019 | Aug 31, 2019 |
| 10-Q | Quarterly report | Jul 15, 2019 | May 31, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 11, 2019 | Jul 10, 2019 |
| DEF 14C | Information statement | Jun 27, 2019 | Jun 26, 2019 |
| PRE 14C | Filing | Jun 17, 2019 | Jun 17, 2019 |
| 8-K |
Current report
Officer or director change
|
Jun 11, 2019 | Jun 10, 2019 |
| 10-Q | Quarterly report | Mar 27, 2019 | Feb 28, 2019 |
| 10-Q | Quarterly report | Jan 22, 2019 | Nov 30, 2018 |
| NT 10-Q | Filing | Jan 15, 2019 | Nov 30, 2018 |
| 8-K |
Current report
Auditor change
|
Dec 10, 2018 | Dec 6, 2018 |
| 8-K |
Current report
Officer or director change
|
Nov 16, 2018 | Nov 14, 2018 |
| 10-K | Annual report | Nov 13, 2018 | Aug 31, 2018 |
| 10-Q | Quarterly report | Jul 20, 2018 | May 31, 2018 |
| NT 10-Q | Filing | Jul 17, 2018 | May 31, 2018 |
| 10-Q | Quarterly report | Apr 16, 2018 | Feb 28, 2018 |
| 10-Q | Quarterly report | Jan 16, 2018 | Nov 30, 2017 |
| 10-K | Annual report | Dec 18, 2017 | Aug 31, 2017 |
| NT 10-K | Filing | Nov 30, 2017 | Aug 31, 2017 |
| 10-Q | Quarterly report | Jul 24, 2017 | May 31, 2017 |
| NT 10-Q | Filing | Jul 17, 2017 | May 31, 2017 |
| 10-Q | Quarterly report | Apr 13, 2017 | Feb 28, 2017 |
| 10-Q | Quarterly report | Jan 23, 2017 | Nov 30, 2016 |
| NT 10-Q | Filing | Jan 17, 2017 | Nov 30, 2016 |
| 10-K | Annual report | Dec 12, 2016 | Aug 31, 2016 |
| NT 10-K | Filing | Nov 30, 2016 | Aug 31, 2016 |
| 10-Q | Quarterly report | Jul 20, 2016 | May 31, 2016 |
| NT 10-Q | Filing | Jul 18, 2016 | May 31, 2016 |
| 10-Q | Quarterly report | Apr 14, 2016 | Feb 29, 2016 |
| 10-Q | Quarterly report | Jan 14, 2016 | Nov 30, 2015 |
| 8-K |
Current report
Auditor change
|
Jan 5, 2016 | Jan 5, 2016 |
| 10-K | Annual report | Dec 16, 2015 | Aug 31, 2015 |
| NT 10-K | Filing | Dec 1, 2015 | Aug 31, 2015 |
| 10-Q | Quarterly report | Jul 20, 2015 | May 31, 2015 |
| NT 10-Q | Filing | Jul 16, 2015 | May 31, 2015 |
| EFFECT | Filing | Apr 20, 2015 | — |
| POS AM | Filing | Apr 17, 2015 | — |
| 10-Q | Quarterly report | Apr 16, 2015 | Feb 28, 2015 |
| NT 10-Q | Filing | Apr 14, 2015 | Feb 28, 2015 |
| D | Filing | Apr 2, 2015 | — |
| 10-Q | Quarterly report | Feb 27, 2015 | Nov 30, 2014 |
| 8-A12G | Filing | Feb 24, 2015 | — |
| EFFECT | Filing | Jan 12, 2015 | — |
| CORRESP | Letter to the SEC | Jan 9, 2015 | — |
| S-1/A | Amended registration statement | Jan 7, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2014 | — |
| S-1/A | Amended registration statement | Dec 17, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2014 | — |
| S-1/A | Amended registration statement | Oct 31, 2014 | — |
| S-1 | Registration statement | Apr 1, 2014 | — |
Showing 122 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AGTX (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Dana Point, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1603345
- Former names
- FairWind Energy Inc. (until Jun 27, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.